232 related articles for article (PubMed ID: 23575475)
1. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer.
Ma F; Li X; Ren J; Guo R; Li Y; Liu J; Sun Y; Liu Z; Jia J; Li W
Cell Death Dis; 2019 Aug; 10(9):623. PubMed ID: 31423012
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
7. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
8. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
[TBL] [Abstract][Full Text] [Related]
10. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
11. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
Wang L; Ouyang L
Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.
Wang Z; Chen J; Sun J; Cui Z; Wu H
World J Surg Oncol; 2012 Jun; 10():119. PubMed ID: 22734884
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
[TBL] [Abstract][Full Text] [Related]
15. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
[TBL] [Abstract][Full Text] [Related]
17. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
18. RalBP1 is necessary for metastasis of human cancer cell lines.
Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
[TBL] [Abstract][Full Text] [Related]
19. Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).
Yue MM; Lv K; Meredith SC; Martindale JL; Gorospe M; Schuger L
J Biol Chem; 2014 Dec; 289(49):33971-83. PubMed ID: 25336651
[TBL] [Abstract][Full Text] [Related]
20. EIF3B promotes cancer progression in pancreatic cancer.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
